Greene, S. J., Gheorghiade, M., Borlaug, B. A., Pieske, B., Vaduganathan, M., Burnett, J. C., … Butler, J. (2013). The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J Am Heart Assoc, 2(6), e000536. https://doi.org/10.1161/JAHA.113.000536

Greene, Stephen J., Mihai Gheorghiade, Barry A. Borlaug, Burkert Pieske, Muthiah Vaduganathan, John C. Burnett, Lothar Roessig, et al. “The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.” J Am Heart Assoc 2, no. 6 (December 11, 2013): e000536. https://doi.org/10.1161/JAHA.113.000536.

Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC, et al. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J Am Heart Assoc. 2013 Dec 11;2(6):e000536.

Greene, Stephen J., et al. “The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.” J Am Heart Assoc, vol. 2, no. 6, Dec. 2013, p. e000536. Pubmed, doi:10.1161/JAHA.113.000536.

Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC, Roessig L, Stasch J-P, Solomon SD, Paulus WJ, Butler J. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J Am Heart Assoc. 2013 Dec 11;2(6):e000536.